FABRAZYME

Agalsidase beta · Genzyme Corporation

Drug timelines are a Plus or Pro feature.

31 regulatory and trial events tracked for FABRAZYME, covering 2006-09-29 to 2025-10-21. Get the full timeline:

Most recent: Clinical Trial Update: A Prospective Study to Investigate Safety and Tolerability of Shorter Infusion of Fabrazyme [Phase 4]